NCT05508581

Brief Summary

Lower-limb varicose veins (VVs) are the most common of vascular diseases and affect up to one-third of the population, severely affecting the quality of life (QoL) of patients. In past decades, traditional surgical ligation and stripping were the gold standard therapy for patients with VVs; however, traditional methods have demonstrated high complication and recurrence rates. Thus, the practices are moving toward minimally invasive alternatives.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 22, 2021

Completed
10 months until next milestone

First Posted

Study publicly available on registry

August 19, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2023

Completed
Last Updated

July 30, 2024

Status Verified

July 1, 2024

Enrollment Period

12 months

First QC Date

October 22, 2021

Last Update Submit

July 29, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • 1.Number of Participants with Lack of flow or closed great saphenous vein

    Complete ablation of varicose veins done or if any residual remind

    6 months

  • 2.Operation time

    The time of the whole procedure

    Intraoperative

Secondary Outcomes (2)

  • 1. Number of Participants with recurrence varicose vein varicose veins reappear again after the operation

    12 month

  • 2. Number of Participants with adverse effect of the procedure

    12 months

Study Arms (1)

Varicose veins

OTHER

Ablation of varicose veins by microwaves

Procedure: microwaves ablation of varicose veins

Interventions

Microwave ablation is an endovenous treatment. This is a similar treatment approach as laser ablation and radiofrequency ablation. "Endovenous" means that the treatment device is inside the vein during treatment.

Varicose veins

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 18 and 60 years, either sex, elective admission
  • primary symptomatic VVS (CEAP,C3-C6)
  • Recurrent Varicose Veins after surgery
  • Greater saphenous vein diameter up to 3 cm
  • Greater saphenous vein with variable depth even with depth less than 6mm
  • Greater saphenous vein with tortuosity
  • Diabetic patient with risk of wound infection after surgery
  • Patient with hostile groin
  • Availability of patients for all follow-up visits

You may not qualify if:

  • secondary Varicose Veins
  • Acute thrombosis near the Saphenous-femoral junction
  • Recanalized Greater saphenous vein
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asyut University Hospitals, Faculty of Medicine, Department of Vascular Surgery .Timeframe of the study: 2 years

Asyut, Egypt

Location

MeSH Terms

Conditions

Varicose Veins

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Mohamed Gamal glal, Lecturer

    Lecturer at Vascular and endovascular surgery department Assuit University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

October 22, 2021

First Posted

August 19, 2022

Study Start

November 1, 2022

Primary Completion

October 31, 2023

Study Completion

December 15, 2023

Last Updated

July 30, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations